Abiopharma

Director WICHMANN DAVID S 🟢 acquired 3.8K shares of BOSTON SCIENTIFIC CORP (BSX) Transaction Date: May 07, 2026 | Filing ID: 005114

Director Weber Christophe Pierre 🟢 acquired 5.6K shares (1 derivative) of BOSTON SCIENTIFIC CORP (BSX) Transaction Date: May 07, 2026 | Filing ID: 005113

Director Smith Cathy R 🟢 acquired 6.0K shares (2 derivative) of BOSTON SCIENTIFIC CORP (BSX) Transaction Date: May 07, 2026 | Filing ID: 005112

Fipps Paul 🟡 adjusted position in 156 shares (2 derivative) of ServiceNow, Inc. (NOW) at $93.59 Transaction Date: May 07, 2026 | Filing ID: 000023

📋 MPM Asset Management LLC (Shareholder) plans to sell 13K shares of Werewolf Therapeutics, Inc. (at $0.68 each, total $9K) Filed: May 11, 2026 | ID: 033577

Canney Jacqueline P 🟡 adjusted position in 1.5K shares (1 derivative) of ServiceNow, Inc. (NOW) at $93.59 Transaction Date: May 07, 2026 | Filing ID: 000024

(95% Positive) KORE GROUP HOLDINGS, INC. (KORE) Reports Q2 2026 Financial Results

Fontaine Danielle 🟡 adjusted position in 106 shares (1 derivative) of ServiceNow, Inc. (NOW) at $93.59 Transaction Date: May 07, 2026 | Filing ID: 000008

Director ALLEN BEN F 🟡 adjusted position in 0 shares (1 derivative) of ASURE SOFTWARE INC (ASUR) at $7.86 Transaction Date: May 07, 2026 | Filing ID: 033574

📋 MPM BioVentures 2014, L.P. (Shareholder) plans to sell 84K shares of Werewolf Therapeutics, Inc. (at $0.68 each, total $57K) Filed: May 11, 2026 | ID: 033575